SG Americas Securities, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 120 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$147
-99.9%
12,791
-40.3%
0.00%
-33.3%
Q3 2022$270,000
-69.4%
21,432
-74.3%
0.00%
-66.7%
Q2 2022$881,000
-77.1%
83,282
-64.8%
0.01%
-67.9%
Q1 2022$3,851,000
+4.4%
236,845
-11.0%
0.03%
+40.0%
Q4 2021$3,687,000
-23.3%
266,215
-20.4%
0.02%
-13.0%
Q3 2021$4,805,000
+2866.0%
334,378
+3166.7%
0.02%
+2200.0%
Q2 2021$162,000
-76.8%
10,236
-85.1%
0.00%
-75.0%
Q1 2021$697,000
+61.0%
68,533
+18.0%
0.00%
+100.0%
Q4 2020$433,000
-40.3%
58,085
-72.5%
0.00%
-60.0%
Q3 2020$725,000
-83.7%
211,071
-77.4%
0.01%
-86.5%
Q2 2020$4,455,000
+3464.0%
934,948
+1399.6%
0.04%
+3600.0%
Q1 2020$125,000
+78.6%
62,346
+208.6%
0.00%0.0%
Q4 2019$70,000
-58.6%
20,200
-2.6%
0.00%
-50.0%
Q1 2019$169,000
+19.9%
20,744
-23.1%
0.00%
+100.0%
Q3 2017$141,000
+85.5%
26,990
+98.6%
0.00%0.0%
Q2 2017$76,000
-25.5%
13,588
+11.8%
0.00%0.0%
Q1 2017$102,000
-44.3%
12,152
-58.1%
0.00%
-50.0%
Q4 2016$183,000
+221.1%
28,983
+43.8%
0.00%
Q1 2016$57,000
-52.5%
20,154
+151.0%
0.00%
-100.0%
Q2 2015$120,000
-46.7%
8,031
-56.5%
0.00%0.0%
Q4 2014$225,000
+70.5%
18,483
+78.3%
0.00%0.0%
Q2 2014$132,000
+22.2%
10,369
+1.6%
0.00%
Q1 2014$108,000
+217.6%
10,207
-53.3%
0.00%
Q2 2013$34,00021,8700.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders